Clinical Trials Browser

Phase 1 × Unknown × dalpiciclib × Clear all

NCT06225921 2024-03-06

Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas

Phase 1 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05515289 2023-03-10

Study of SHR6390 in Renal Insufficiency and Healthy Subjects

Phase 1 Unknown

Breast Neoplasms